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Summary Host genetic factors may play a key role in determining the long-term outcome of
the Helicobacter pylori (H. pylori) infection. Toll-like receptor 4 (TLR4) mediated recognition
of lipo-polysaccharide (LPS) is required for efficient recognition of gram-negative bacterial
infections. The aim of this study is to investigate the effects of common polymorphisms of
TLR4 Asp299Gly, Thr399Ile in patients with gastroduodenal diseases in Japanese population.
The study was performed in 149 gastric cancer (GC) cases (mean age 64.0 ± 12.4,
M:F = 109:40) and 94 patients without evidence of GC (mean age 64.1 ± 12.3, M:F = 65:25) as
the control group. TLR4 Asp299Gly, Thr399Ile were determined by Polymerase chain
reaction-length of polymorphisms (PCR-RFLP) in all the patients. Asp299Gly, Thr399Ile were
not detected in all 243 patients enrolled in this study. In conclusion, our data suggest that
TLR4 Asp299Gly, Thr399Ile are very rare in Japanese population and thus they may not be
a important factor in determining the outcome of H. pylori infected individuals in Japan.
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Introduction
Helicobacter pylori (H. pylori) infection is now accepted
as a crucial event in the development of peptic ulcer disease
and atrophic gastritis, and it is implicated in the development
of gastric carcinoma [1–5]. However, there are distinct
differences in the extent of gastric mucosal inflammation and
atrophy among H. pylori infected patients, and only a small
group of them develop peptic ulcer disease and gastric cancer.
It suggests that some genetic factors may play important
roles in long term outcome of H. pylori infection [6].
Toll-like receptor 4 (TLR4) is important mediator of the
inflammatory response in the first line of host defense by
recognition of Lipopolysaccharide (LPS) [7–9]. LPS, a major
component of the outer cell wall of gram-negative bacteria,
is a potent and well-characterized inducer of inflammation.
After forming a complex with the LPS- binding protein, LPS
interacts with a membrane molecule, CD14 and MD2 [10–
12]. Together with TLR4, this complex induces second-
messenger and signal transduction pathways [13]. These
signals in turn activate transcription factors, mainly nuclear
factor-κB (NFκB) and cytokines [10, 14].
Recently it was reported that TLR4 expression by gastric
epithelium was more stronger in H. pylori gastritis than in
the non in inflamed gastric mucosa [15]. It was also reported
that TLR4 regulated the response of gastric epithelial cells to
H. pylori infection and H. pylori LPS-induced transcription
of several genes depends on the activation of NFκB
[16]. These findings support a sentinel role for TLR4 in the
mucosal immunity to H. pylori.
Genetic studies of TLR4 have identified polymorphisms.
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Arbour  et al. [17] demonstrated 2 cosegregating poly-
morphisms in the extracellular domain of the TLR4 gene.
The first is an A-G substitution at nucleotide 896 from
the start codon of the TLR4 gene, which results in an
aspartic acid-to-glycine substitution at position 299 of the
amino acid sequence (Asp299Gly). A cosegregating poly-
morphism that results in a thereonine-to-isoleucine substitution
at position 399 of the amino acid sequence (Thr399Ile) also
was identified. These polymorphisms are associated with
functional changes, as demonstrated by decreased airway
responsiveness after LPS stimulation [18].
Because of the important roles that TLR4 play with
respect to LPS binding and signaling, we hypothesized that
polymorphisms in the TLR4 gene may be important factors
for determining the long term outcome of the H. pylori
infection.
In the present study, we investigated the effects of TLR4
(Asp299Gly, Thr399Ile) polymorphisms on gastroduodenal
diseases in Japanese population.
Subjects and Methods
Study Population
We studied 243 patients attending the gastroenterology
division of Fujita Health University Hospital (Aichi, Japan)
from January 2005 to January 2006. Gastroscopy was
done in all of the patients and they were divided into two
groups for assessment of TLR4 polymorphisms. There were
149 gastric cancer (GC) patients with a mean age of 64.0
(29–91) years and a male:female (M:F) ratio of 109:40 and
94 patients with no evidence of GC (mean age of 64.1 [30–
90] years old and M:F = 65:29) as the control group. GC
was diagnosed histologically and was classified according
to Lauren’s classification [18]. Detailed information was
obtained about staging and anatomic location (Table 1). The
Ethics Committee of Fujita Health University School of
Medicine approved the protocol and written informed
consent was obtained from all of the subjects.
Detection of H. pylori
H. pylori infection status was determined by histology,
culture, the rapid urease test (RUT), or the serum titer of
antibodies against H. pylori. Infection was diagnosed when
at least one of these tests was positive.
Genotyping
Genomic DNA was extracted from non-cancerous gastric
biopsy tissue or peripheral blood using the standard phenol/
chloroform method. Then Asp299Gly, Thr399Ile poly-
morphisms of TLR4 were determined using PCR and sub-
sequent cleavage by NcoI and HinfI restriction endnucleases
as previously described [19].
Results
Study population
A total of 149 GC patients and 94 control subjects
without evidence of GC participated in this study. Their
characteristics are summarized in Table 2. There were no
significant differences between these groups in the distribution
of age and sex, but the H. pylori infection rate was
significantly higher in the GC patients (p = 0.0002). The
control group included 25 patients gastric ulcer (26.7%),
7 patients with duodenal ulcer (7.4%) and patients with
gastric + duodenal ulcer (2.1%). They were all H. pylori
positives.
TLR4 genotypes
Asp299Gly, Thr399Ile polymorphisms of TLR4 were
typed in all 243 subjects. However, in this study, Asp299Gly
and Thr399Ile polymorphisms of TLR4 were not detected in
all the 243 subjects.
Discussion
H. pylori LPS has not been considered to play a major
Table 1. Clinicopathologic characteristics of GC
Variables (n)
Histrogic subtypes
Intestinal type 85
Diffuse type 64
Tumor location
Cardia 6
Non cardia 143
Upper third 4
Middle third 84
Lower third 55
Tumor stage
Early stage 62
Advanced stage 73
Table 2. Characteristics of subjects
Gastric cancer 
(GC) cases
Patients 
without GC
p
Subjects (n) 149 104
Sex [male/female 
(%/%)]
109/40 (73/27) 65/29 (69/31) 0.53$
Mean age ± SD (y) 64.0 ± 12.4 64.1 ± 12.3 0.76*
H. pylori infection 
positive ratio (%)
90.6 72.3 0.002$
$x2 test, *Mann-Whitney U testT. Tahara et al.
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role in the pathogenesis of gastritis because its biological
activity is lower than that of the LPS of pathogens such
as  Escherichia coli ( E.coli) and Salmonella  species
(Salmonella spp) [20, 21]. But in contrast, several studies
have demonstrated significant roles of H. pylori LPS in the
induction of gastritis. Teshima et al. [22, 23] have shown
that H. pylori LPS stimulates NF-κB activation markedly
in cultured guinea pig gastric mucosal cells and leads to
abundant release of superoxide anion from the cells. In
addition, the severity of atrophic gastritis induced by long
term infection of Haemobartonella felis in CH3/He mice is
significantly higher than that in LPS-non responder CH3/
HeJ mice [24], which have an inactivating point mutation in
TLR4 [25]. More recently, Karhukorpi et al. [26] reported
elevated serum levels of a soluble form of the CD14
molecule in H. pylori infected individuals. Soluble CD14
binds to LPS and facilitates its signaling, and this study has
shown that CD14 promoter polymorphism is associated with
the disease outcome. All of these findings suggest that H.
pylori LPS may be a potent mediator in modulating H.
pylori infection induced gastritis and it may be reasonable
to speculate that inter individual difference of innate
immune response to H. pylori LPS is a important factor in
determining the long term out come of the H. pylori infec-
tion.
TLR4-mediated recognition of LPS is required for
efficient recognition of Gram-negative bacterial infections
and some studies shows important roles that TLR4 plays
with respect to LPS binding and signaling even in H. pylori
infection [16].
In 2000, Arbor et al. reported that TLR4 polymorphisms
Asp299Gly, Thr399Ile lead to a LPS-hyporesponsive pheno-
type in either human primary airway epithelial cells or
alveolar macrophages [17]. Concerning host genetic factors,
polymorphisms in TLR4 show an increased risk to develop
a septic shock with gram negative microorganisms [27],
premature birth [28], graft versus host disease after hemato-
poietic stem cell transplantation [29], and inflammatory
bowel disease [30]. But in this study, we did not detect
299Gly or 399Ile alleles in patients with gastroduodenal
diseases in Japanese population. All 243 subjects did not
have 299Gly and 399Ile polymorphisms of TLR4. Noguchi
et al. screened 32 Japanese asthmatics and did not detect
299Gly or 399Ile polymorphisms of TLR4 [31]. Similar
results has also been reported in other studies in China [32,
33]. 299Gly and 399Ile polymorphisms of TLR4 may be
very rare at least in Japanese and Chinese population and
thus may not be an important factor in determining the
outcome of the H. pylori infected patients in this area.
Recently, Ohara et al. reported the potential association
between TLR4 Thr 135 Ala polymorphism at leucine-rich
repeat (LRR) of toll-like receptor 4 and risk of diffuse
type gastric cancer in Japanese population [34]. This poly-
morphism but not 299Gly or 399Ile may influence the
function of TLR4 and modify the risk of H. pylori related
gastrodduodenal diseases in Japanese population.
In conclusion, we have shown that 299Gly and 399Ile
polymorphisms of TLR4 are very rare in patients with
gastroduodenal diseases in Japan. Further genetic studies
will be needed to resolve the impact of the TLR4 poly-
morphisms in the susceptibility of gastroduodenal diseases
in Japanese population.
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